02
Sep
2010
Otonomy, Inc.: Series B $38.5M
Posted in I - Series B, Q - 3Q10, R - WEST, X - Hearing Loss, X - Ménière's, X - Tinnitus, XX - CA
Otonomy (San Diego, CA) a clinical-stage biopharmaceutical company focused on, hearing and balance disorders such as Ménière’s disease, hearing loss, and tinnitus. closed a $38.5M Series B financing. Participants include Novo Ventures, RiverVest Venture Partners, Domain Associates and TPG Biotech.
OnBioVC PARTNERS
-
